Global Drug Repositioning Service Market Research Report 2025(Status and Outlook)

March 2025 | 136 pages | ID: GCD10C9F90AEEN
Bosson Research

Abstracts

Report Overview

Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.

This report provides a deep insight into the global Drug Repositioning Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Repositioning Service Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Repositioning Service market in any manner.

Global Drug Repositioning Service Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Biovista

Anaxomics Biotech

Segue Therapeutics

GVK Biosciences

LTT Bio-Pharma

Market Segmentation (by Type)

Generic Drugs

Clinical Trial Failed Drugs

Market Segmentation (by Application)

Cardiovascular Diseases

Mental Illness

Cancer

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Drug Repositioning Service Market
• Overview of the regional outlook of the Drug Repositioning Service Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Repositioning Service Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Drug Repositioning Service
1.2 Key Market Segments
1.2.1 Drug Repositioning Service Segment by Type
1.2.2 Drug Repositioning Service Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Drug Repositioning Service Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Drug Repositioning Service Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Drug Repositioning Service Product Life Cycle
3.3 Global Drug Repositioning Service Revenue Market Share by Company (2020-2025)
3.4 Drug Repositioning Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Drug Repositioning Service Company Headquarters, Area Served, Product Type
3.6 Drug Repositioning Service Market Competitive Situation and Trends
3.6.1 Drug Repositioning Service Market Concentration Rate
3.6.2 Global 5 and 10 Largest Drug Repositioning Service Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Development and Dynamics of Drug Repositioning Service Market
4.1 Key Development Trends
4.2 Driving Factors
4.3 Market Challenges
4.4 Market Restraints
4.5 Industry News
4.5.1 New Product Developments
4.5.2 Mergers & Acquisitions
4.5.3 Expansions
4.5.4 Collaboration/Supply Contracts
4.6 PEST Analysis
4.6.1 Industry Policies Analysis
4.6.2 Economic Environment Analysis
4.6.3 Social Environment Analysis
4.6.4 Technological Environment Analysis
4.7 Global Drug Repositioning Service Market Porter's Five Forces Analysis
5 Global Drug Repositioning Service Market Segmentation by Region
5.1 Global Drug Repositioning Service Market Size by Region
5.2 Global Drug Repositioning Service Market Size by Country
6 North America Market Overview
6.1 North America Drug Repositioning Service Market Size by Country
6.1.1 USA Market Overview
6.1.2 Canada Market Overview
6.1.3 Mexico Market Overview
6.2 North America Drug Repositioning Service Market Size by Type
6.3 North America Drug Repositioning Service Market Size by Application
7 Europe Market Overview
7.1 Europe Drug Repositioning Service Market Size by Country
7.1.1 Germany Market Overview
7.1.2 France Market Overview
7.1.3 U.K. Market Overview
7.1.4 Italy Market Overview
7.1.5 Spain Market Overview
7.2 Europe Drug Repositioning Service Market Size by Type
7.3 Europe Drug Repositioning Service Market Size by Application
8 Asia-Pacific Market Overview
8.1 Asia-Pacific Drug Repositioning Service Market Size by Country
8.1.1 China Market Overview
8.1.2 Japan Market Overview
8.1.3 South Korea Market Overview
8.1.4 India Market Overview
8.1.5 Southeast Asia Market Overview
8.2 Asia-Pacific Drug Repositioning Service Market Size by Type
8.3 Asia-Pacific Drug Repositioning Service Market Size by Application
9 South America Market Overview
9.1 South America Drug Repositioning Service Market Size by Country
9.1.1 Brazil Market Overview
9.1.2 Argentina Market Overview
9.1.3 Columbia Market Overview
9.2 South America Drug Repositioning Service Market Size by Type
9.3 South America Drug Repositioning Service Market Size by Application
10 Middle East and Africa Market Overview
10.1 Middle East and Africa Drug Repositioning Service Market Size by Country
10.1.1 Saudi Arabia Market Overview
10.1.2 UAE Market Overview
10.1.3 Egypt Market Overview
10.1.4 Nigeria Market Overview
10.1.5 South Africa Market Overview
10.2 Middle East and Africa Drug Repositioning Service Market Size by Type
10.3 Middle East and Africa Drug Repositioning Service Market Size by Application
11 Drug Repositioning Service Market Segmentation by Type
11.1 Evaluation Matrix of Segment Market Development Potential (Type)
11.2 Global Drug Repositioning Service Market Share by Type (2020-2033)
11.3 Global Drug Repositioning Service Growth Rate by Type (2020-2033)
12 Drug Repositioning Service Market Segmentation by Application
12.1 Evaluation Matrix of Segment Market Development Potential (Application)
12.2 Global Drug Repositioning Service Market Size (M USD) by Application (2020-2033)
12.3 Global Drug Repositioning Service Growth Rate by Application (2020-2033)
13 Key Companies Profile
13.1 Biovista
13.1.1 Biovista Basic Information
13.1.2 Biovista Drug Repositioning Service Product Overview
13.1.3 Biovista Drug Repositioning Service Product Market Performance
13.1.4 Biovista Drug Repositioning Service SWOT Analysis
13.1.5 Biovista Business Overview
13.1.6 Biovista Recent Developments
13.2 Anaxomics Biotech
13.2.1 Anaxomics Biotech Basic Information
13.2.2 Anaxomics Biotech Drug Repositioning Service Product Overview
13.2.3 Anaxomics Biotech Drug Repositioning Service Product Market Performance
13.2.4 Anaxomics Biotech Drug Repositioning Service SWOT Analysis
13.2.5 Anaxomics Biotech Business Overview
13.2.6 Anaxomics Biotech Recent Developments
13.3 Segue Therapeutics
13.3.1 Segue Therapeutics Basic Information
13.3.2 Segue Therapeutics Drug Repositioning Service Product Overview
13.3.3 Segue Therapeutics Drug Repositioning Service Product Market Performance
13.3.4 Segue Therapeutics Drug Repositioning Service SWOT Analysis
13.3.5 Segue Therapeutics Business Overview
13.3.6 Segue Therapeutics Recent Developments
13.4 GVK Biosciences
13.4.1 GVK Biosciences Basic Information
13.4.2 GVK Biosciences Drug Repositioning Service Product Overview
13.4.3 GVK Biosciences Drug Repositioning Service Product Market Performance
13.4.4 GVK Biosciences Business Overview
13.4.5 GVK Biosciences Recent Developments
13.5 LTT Bio-Pharma
13.5.1 LTT Bio-Pharma Basic Information
13.5.2 LTT Bio-Pharma Drug Repositioning Service Product Overview
13.5.3 LTT Bio-Pharma Drug Repositioning Service Product Market Performance
13.5.4 LTT Bio-Pharma Business Overview
13.5.5 LTT Bio-Pharma Recent Developments
14 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Drug Repositioning Service Market Size by Type (M USD)
Table 4. Global Drug Repositioning Service Market Size by Application (M USD)
Table 5. Drug Repositioning Service Market Size Comparison by Region (M USD)
Table 6. Global Drug Repositioning Service Revenue (M USD) by Company (2020-2025)
Table 7. Global Drug Repositioning Service Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning Service as of 2024)
Table 9. Drug Repositioning Service Company Headquarters and Area Served
Table 10. Company Drug Repositioning Service Product Type
Table 11. Global Drug Repositioning Service Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Key Development Trends
Table 14. Driving Factors
Table 15. Drug Repositioning Service Market Challenges
Table 16. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 17. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 18. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 19. Drug Repositioning Service Market Size Comparison by Region (M USD)
Table 20. Global Drug Repositioning Service Market Size by Region (2020-2033) & (M USD)
Table 21. Global Drug Repositioning Service Market Share by Region (2020-2025)
Table 22. North America Drug Repositioning Service Market Size by Country (2020-2033) & (M USD)
Table 23. North America Drug Repositioning Service Market Size by Type (M USD)
Table 24. North America Drug Repositioning Service Market Size (M USD) by Type (2020-2033)
Table 25. North America Drug Repositioning Service Market Size by Application (M USD)
Table 26. North America Drug Repositioning Service Market Size (M USD) by Application (2020-2033)
Table 27. Europe Drug Repositioning Service Market Size by Country (2020-2033) & (M USD)
Table 28. Europe Drug Repositioning Service Market Size by Type (M USD)
Table 29. Europe Drug Repositioning Service Market Size (M USD) by Type (2020-2033)
Table 30. Europe Drug Repositioning Service Market Size by Application (M USD)
Table 31. Europe Drug Repositioning Service Market Size (M USD) by Application (2020-2033)
Table 32. Asia-Pacific Drug Repositioning Service Market Size by Country (2020-2025) & (M USD)
Table 33. Asia-Pacific Drug Repositioning Service Market Size by Type (M USD)
Table 34. Asia-Pacific Drug Repositioning Service Market Size (M USD) by Type (2020-2025)
Table 35. Asia-Pacific Drug Repositioning Service Market Size by Application (M USD)
Table 36. Asia-Pacific Drug Repositioning Service Market Size (M USD) by Application (2020-2025)
Table 37. South America Drug Repositioning Service Market Size by Country (2020-2033) & (M USD)
Table 38. South America Drug Repositioning Service Market Size by Type (M USD)
Table 39. South America Drug Repositioning Service Market Size (M USD) by Type (2020-2033)
Table 40. South America Drug Repositioning Service Market Size by Application (M USD)
Table 41. South America Drug Repositioning Service Market Size (M USD) by Application (2020-2033)
Table 42. Middle East and Africa Drug Repositioning Service Market Size by Country (2020-2033) & (M USD)
Table 43. Middle East and Africa Drug Repositioning Service Market Size by Type (M USD)
Table 44. Middle East and Africa Drug Repositioning Service Market Size (M USD) by Type (2020-2033)
Table 45. Middle East and Africa Drug Repositioning Service Market Size by Application (M USD)
Table 46. Middle East and Africa Drug Repositioning Service Market Size (M USD) by Application (2020-2033)
Table 47. Global Drug Repositioning Service Market Size by Type (M USD)
Table 48. Global Drug Repositioning Service Market Size (M USD) by Type (2020-2033)
Table 49. Global Drug Repositioning Service Market Share by Type (2020-2033)
Table 50. Global Drug Repositioning Service Market Size by Application(M USD)
Table 51. Global Drug Repositioning Service Market Size by Application (2020-2033) & (M USD)
Table 52. Global Drug Repositioning Service Market Share by Application (2020-2033)
Table 53. Global Drug Repositioning Service Growth Rate by Application (2020-2033)
Table 54. Biovista Basic Information
Table 55. Biovista Drug Repositioning Service Product Overview
Table 56. Biovista Drug Repositioning Service Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Biovista Drug Repositioning Service SWOT Analysis
Table 58. Biovista Business Overview
Table 59. Biovista Recent Developments
Table 60. Anaxomics Biotech Basic Information
Table 61. Anaxomics Biotech Drug Repositioning Service Product Overview
Table 62. Anaxomics Biotech Drug Repositioning Service Revenue (M USD) and Gross Margin (2020-2025)
Table 63. Anaxomics Biotech Drug Repositioning Service SWOT Analysis
Table 64. Anaxomics Biotech Business Overview
Table 65. Anaxomics Biotech Recent Developments
Table 66. Segue Therapeutics Basic Information
Table 67. Segue Therapeutics Drug Repositioning Service Product Overview
Table 68. Segue Therapeutics Drug Repositioning Service Revenue (M USD) and Gross Margin (2020-2025)
Table 69. Segue Therapeutics Drug Repositioning Service SWOT Analysis
Table 70. Segue Therapeutics Business Overview
Table 71. Segue Therapeutics Recent Developments
Table 72. GVK Biosciences Basic Information
Table 73. GVK Biosciences Drug Repositioning Service Product Overview
Table 74. GVK Biosciences Drug Repositioning Service Revenue (M USD) and Gross Margin (2020-2025)
Table 75. GVK Biosciences Business Overview
Table 76. GVK Biosciences Recent Developments
Table 77. LTT Bio-Pharma Basic Information
Table 78. LTT Bio-Pharma Drug Repositioning Service Product Overview
Table 79. LTT Bio-Pharma Drug Repositioning Service Revenue (M USD) and Gross Margin (2020-2025)
Table 80. LTT Bio-Pharma Business Overview
Table 81. LTT Bio-Pharma Recent Developments
List of Figures
Figure 1. Industry Chain of Drug Repositioning Service
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Repositioning Service Market Size (M USD), 2024-2033
Figure 5. Global Drug Repositioning Service Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Drug Repositioning Service Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Drug Repositioning Service Product Life Cycle
Figure 12. Global Drug Repositioning Service Revenue Share by Company in 2024
Figure 13. Drug Repositioning Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Drug Repositioning Service Revenue in 2024
Figure 15. Global Drug Repositioning Service Market PESTE Analysis
Figure 16. Global Drug Repositioning Service Market Porter's Five Forces Analysis
Figure 17. Evaluation Matrix of Regional Market Development Potential
Figure 18. Global Drug Repositioning Service Market Size by Region
Figure 19. Global Drug Repositioning Service Market Size by Country (M USD)
Figure 20. North American Market Snapshot
Figure 21. North America Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 22. North America Drug Repositioning Service Market Size (M USD) by Country
Figure 23. USA Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 24. Canada Drug Repositioning Service Market Size (M USD) and Growth Rate (2020-2033)
Figure 25. Mexico Drug Repositioning Service Market Size (M USD) and Growth Rate (2020-2033)
Figure 26. North America Drug Repositioning Service Market Size (M USD) by Type
Figure 27. North America Drug Repositioning Service Market Size (M USD) by Application
Figure 28. Europe Market Snapshot
Figure 29. Europe Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 30. Europe Drug Repositioning Service Market Size (M USD) by Country
Figure 31. Germany Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. France Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 33. U.K. Drug Repositioning Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Italy Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Spain Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 36. Europe Drug Repositioning Service Market Size (M USD) by Type
Figure 37. Europe Drug Repositioning Service Market Size (M USD) by Application
Figure 38. Asia-Pacific Market Snapshot
Figure 39. Asia-Pacific Drug Repositioning Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia-Pacific Drug Repositioning Service Market Size (M USD) by Country
Figure 41. China Drug Repositioning Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 42. Japan Drug Repositioning Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. South Korea Drug Repositioning Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. India Drug Repositioning Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. Southeast Asia Drug Repositioning Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Asia-Pacific Drug Repositioning Service Market Size (M USD) by Type
Figure 47. Asia-Pacific Drug Repositioning Service Market Size (M USD) by Application
Figure 48. South America Market Snapshot
Figure 49. South America Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 50. South America Drug Repositioning Service Market Size (M USD) by Country
Figure 51. Brazil Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 52. Argentina Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Columbia Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 54. South America Drug Repositioning Service Market Size (M USD) by Type
Figure 55. South America Drug Repositioning Service Market Size (M USD) by Application
Figure 56. Middle East and Africa Market Snapshot
Figure 57. Middle East and Africa Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 58. Middle East and Africa Drug Repositioning Service Market Size (M USD) by Country
Figure 59. Saudi Arabia Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 60. UAE Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 61. Egypt Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 62. Nigeria Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 63. South Africa Drug Repositioning Service Market Size and Growth Rate (2020-2033) & (M USD)
Figure 64. Middle East and Africa Drug Repositioning Service Market Size (M USD) by Type
Figure 65. Middle East and Africa Drug Repositioning Service Market Size (M USD) by Application
Figure 66. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 67. Global Drug Repositioning Service Market Size by Type (M USD)
Figure 68. Market Share of Drug Repositioning Service by Type (2020-2033)
Figure 69. Market Share of Drug Repositioning Service by Type in 2024
Figure 70. Global Drug Repositioning Service Growth Rate by Type (2020-2033)
Figure 71. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 72. Global Drug Repositioning Service Market Size by Application (M USD)
Figure 73. Global Drug Repositioning Service Market Share by Application
Figure 74. Global Drug Repositioning Service Market Share by Application (2020-2033)
Figure 75. Global Drug Repositioning Service Market Share by Application in 2024
Figure 76. Global Drug Repositioning Service Growth Rate by Application (2020-2033)